MentionFox
Home › Executive changes › Nakamoto Inc.
Leadership changes · SEC Form 8-K, Item 5.02

Nakamoto Inc. executive changes

Every leadership change Nakamoto Inc. reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings2
Departures named1
Latest filing2026-08-04

Nakamoto Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-04. Between them they name 1 person. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-08-04 · 8-K

Departing: Tim Pickett, Chief Medical Officer, effective 2026-08-03

On August 3, 2026, Tim Pickett resigned from all positions that he held with Nakamoto Inc., a Delaware corporation (the " Company "), and its affiliates, including as a director of the Company, Chief Medical Officer of the Company, and Chief Executive Officer of Kindly LLC, in each case effective August 3, 2026.
Filed 2026-05-22 · 8-K

Reported

Mr. Evans has not entered into any material plan, contract, arrangement or amendment in connection with his appointment to the Board.
Hiring for a seat like this?

Find people with the same kind of experience as the Chief Medical Officer at Nakamoto Inc., with the record behind each one.

Find candidates like Chief Medical Officer at Nakamoto Inc.
Selling to Nakamoto Inc.?

New leaders review vendors and budgets in their first months. Get an alert the next time Nakamoto Inc. is in the news or changes leadership.

Get an alert when Nakamoto Inc. changes leadership

Tools for this story

Each opens in a new tab, filled in for Nakamoto Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/nakamoto
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2
Nakamoto Inc. (NAKA) executive changes: Tim Pickett departs, Chief Medical Officer. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/nakamoto